De Novo Protein Engineering: Future-Proofing MRI Contrast Agents with BlueBEAR

In this case study, we hear from Sarah Berger, a researcher working in Bioinformatics, who has been using BlueBEAR to develop proteins that can bind to metals. Magnetic resonance imaging (MRI) is an essential diagnostic tool, particularly powerful when combined with contrast agents. Most state-of-the-art MRI contrast agents are based on the metal gadolinium, which has intrinsic physical … Continue reading “De Novo Protein Engineering: Future-Proofing MRI Contrast Agents with BlueBEAR”

Published: Posted on